Aged; Belgium; Bone Density; Cost-Benefit Analysis; Female; Fractures, Bone/prevention & control; Humans; Markov Chains; Mass Screening/economics; Middle Aged; Osteoporosis/diagnosis/economics/radiography/ultrasonography; Osteoporosis, Postmenopausal/diagnosis/economics; Public Health; Retrospective Studies; Risk Factors
Abstract :
[en] The Province of Liege has conducted an osteoporosis screening strategy for women aged 50 to 69 years. The objective of this study is to investigate the economic characteristics of the screening strategy and to assess its cost-effectiveness, using a Markov microsimulation model. Our analyses suggest that the osteoporosis screening strategy is efficient if the medical community and the patients fulfill the recommendations of the Province of Liege health authorities and if persistence is optimized. Therefore, bone mineral density (BMD) measurement should be performed in all individuals with positive ultrasound screening; individuals having a positive BMD diagnosis should be treated and adherence to therapy should be increased. Furthermore, to improve the efficiency of the screening strategy, we suggest to target screening on women with one or more clinical risk factors, or on women aged 65 years and older.
Disciplines :
Special economic topics (health, labor, transportation...) Public health, health care sciences & services
Author, co-author :
Hiligsmann, Mickaël ; Université de Liège - ULiège > HEC - École de gestion de l'ULiège > Economie industrielle
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique - Département des sciences de la santé publique
Pire, Georges; Province de Liège
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
French
Title :
Evaluation économique de la campagne de dépistage de l'ostéoporose menée en Province de Liège avec le concours de Liège Province Santé
Alternative titles :
[en] Economic evaluation of osteoporosis screening strategy conducted in the Province of Liège with the cooperation of Liège Province Santé
Hiligsmann M, Bruyère O, Reginster JY. - Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. Rev Med Liege, 2008, 63, 480-487.
Report of a WHO Study Group. - Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser, 1994, 843, 1-129.
Reginster JY, Dethor M, Pirenne H, et al. - Reproducibility and diagnostic sensitivity of ultrasonometry of the phalanges to assess osteoporosis. Int J Gynaecol Obstet, 1998, 63, 21-28.
Cummings SR, Black DM, Thompson DE, et al. - Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA, 1998, 280, 2077-2082.
Krieg MA, Cornuz J, Ruffieux C, et al. - Rôle des ultrasons osseux pour la prédiction du risque de fracture de hanche chez la femme âgée de 70 ans ou plus: résultats de l'étude SEMOF et comparaison avec les données de la littérature: Ostéoporose. Rev Med Suisse romande, 2004, 124, 59-62.
Richy F, Gourlay M, Ross PD, et al. - Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium. Q J Med, 2004, 97, 39-46.
Stevenson M, Davis S. - Analyses of the cost-effectiveness of the pooled alendronate and risedronate, compared with strontium ranelate, raloxifene, etidronate and teriparatide. ScHAAR, 2006.
ECODATA, Service Public Fédéral Economie, PME, Classes Moyennes et Energies.
Boonen S, Kaufman JM, Reginster JY, et al. - Patient assessment using standardized bone mineral density values and a national reference database : implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium. Osteoporos Int, 2003, 14, 110-115.
Raftery J. - NICE : faster access to modern treatments? Analysis of guidance on health technologies. BMJ, 2001, 323, 1300-1303.
Kanis JA, Jonsson B. - Economic evaluation of interventions for osteoporosis. Osteoporos Int, 2002, 13, 765-767.
Boonen S, Body JJ, Boutsen Y, et al. - Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int, 2005, 16, 239-254.
Rabenda V, Mertens R, Fabri V, et al. - Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int, 2008 (sous presse).
Kanis J, Burlet N, Cooper C, et al. - European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int, 2008, sous presse.
